Trial Profile
A retrospective study of starting Insulin in Type 2 Diabetes patients.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 12 Oct 2015
Price :
$35
*
At a glance
- Drugs Insulin glargine (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 12 Oct 2015 New trial record